Journal article
Treatment of Hypercalcemia of Malignancy in Adults: An Endocrine Society Clinical Practice Guideline
Abstract
BACKGROUND: Hypercalcemia of malignancy (HCM) is the most common metabolic complication of malignancies, but its incidence may be declining due to potent chemotherapeutic agents. The high mortality associated with HCM has declined markedly due to the introduction of increasingly effective chemotherapeutic drugs. Despite the widespread availability of efficacious medications to treat HCM, evidence-based recommendations to manage this …
Authors
El-Hajj Fuleihan G; Clines GA; Hu MI; Marcocci C; Murad MH; Piggott T; Van Poznak C; Wu JY; Drake MT
Journal
The Journal of Clinical Endocrinology & Metabolism, Vol. 108, No. 3, pp. 507–528
Publisher
The Endocrine Society
Publication Date
February 15, 2023
DOI
10.1210/clinem/dgac621
ISSN
0021-972X